News
Video
Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the treatment considerations necessary to properly manage a patient with congenital plasminogen deficiency after she became pregnant.
Pharmacy Times® interviewed Per Morten Sandset, MD, a principal investigator and professor in the Department of Haematology and the Research Institute of Internal Medicine at the University of Oslo and Oslo University Hospital, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research conducted to investigate the successful pregnancy of a patient with infertility due to congenital plasminogen deficiency who was treated with intravenous plasminogen replacement therapy.
In this video, Sandset discusses the treatment considerations necessary to properly manage this patient with congenital plasminogen deficiency after she became pregnant.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa